Intra-articular CSI
ProcedureAfter full aseptic preparation, 40 mg triamcinolone acetonide and 2 ml 1% lignocaine were injected into the joint cavity using the medial patello-femoral approach via a 21-gauge needle.
NCT Number: NCT01303666
Previous studies have indicated that patient expectations, beliefs and preferences may have an impact on treatment outcomes. The KIVIS study was primarily designed to compare two effective treatments for knee osteoarthritis (tidal irrigation (medical washout of the knee) or intra-articular corticosteroid injection). At study entry any preference expressed by the patient for each of the treatment interventions was recorded. This study assessed the effects of two treatments given at a single time-point and hence the effects of patient preference could be assessed independently of any compliance issues.
Looking for future studies?
Notify Me40 year–90 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After full aseptic preparation, 40 mg triamcinolone acetonide and 2 ml 1% lignocaine were injected into the joint cavity using the medial patello-femoral approach via a 21-gauge needle.
This was done as a day case procedure under local anaesthetic. The medial patello-femoral approach was used. After full aseptic preparation, the skin and soft tissues were infiltrated with 5e10 ml of 1% lignocaine. The joint was then instilled with a further 10 ml of 1% lignocaine.
After an initial puncture using a scalpel, a 3.2 mm diameter wrist arthroscope was advanced into the joint cavity. Up to 1 l of 0.9% normal saline was then irrigated through the joint: saline was run into the joint until fully distended and then allowed to flow out of the joint in a cyclical method until the aspirated fluid runs clear for at least three successive cycles.
Time frame: Weeks 0
Time frame: Weeks 0
Time frame: Weeks 2
Time frame: Weeks 4
Time frame: Weeks 12
Time frame: Weeks 26
Time frame: Weeks 2
Time frame: Weeks 4
Time frame: Weeks 12
Time frame: Weeks 26
Time frame: Weeks 0,2,4,12,26
Time frame: Weeks 0,2,4,12,26
Time frame: Weeks 0,2,4,12,26
Time frame: Weeks 0,2,4,12,26
Time frame: Weeks 0,2,4,12,26
Time frame: Weeks 0,2,4,12,26
Portsmouth Hospitals NHS Trust
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07166068
Arthritis, Joint Diseases
Jizan, Jazan Region, Saudi Arabia
View Trial DetailsNCT03825965
Arthritis, Chemically-Induced Disorders
Hamilton, Ontario, Canada
View Trial DetailsNCT07047079
Arthritis, Joint Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT07798973
Arthritis, Balance Impairment
Peshawar, KPK, Pakistan
View Trial Details